Dental implant maker Osstem, backed by MKB, is in advanced talks to acquire New York-listed peer ZimVie. ZimVie has been weighing options, including a sale, after receiving fresh takeover approaches. Earlier Bloomberg reports suggested a price range of $25-29 per share for the acquisition. ZimVie has significantly outperformed recently in a weak dental market, with its stock up 14.4% pre-market.
$ZIMV (+14.4% pre) ZimVie (ZIMV) is in Advanced Talks to be Acquired by Osstem Implant - Bloomberg https://t.co/13H9zQPpRM
We're in the final stages for dental implant Zimvie $ZIMV. MKB-Backed Dental Implant Maker Osstem Said in Talks for Zimvie. ZimVie has been 'weighing options' including a sale after getting fresh takeover approaches. Earlier Bloomberg reports suggested a price range of $25-29… https://t.co/0oAjtk7Zyc
$ZIMV has significantly outperformed lately in a very weak dental market, good job @VafaJamali https://t.co/ffmCu4Q3SV